Article Information
History
- February 14, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Deniz Türkmen1,
- Jack Bowden2,3,
- Jane A.H. Masoli1,4,
- João Delgado1,
- Chia-Ling Kuo5,6,
- Luke C. Pilling1 and
- David Melzer1,*
- 1Epidemiology and Public Health Group, College of Medicine and Health, University of Exeter, Exeter, UK
- 2Exeter Diabetes Group (ExCEED), College of Medicine and Health, University of Exeter, Exeter, UK
- 3Department of Genetics, Novo Nordisk Research Centre Oxford, Innovation Building, Old Road Campus, Roosevelt Drive, Oxford, U.K
- 4Department of Healthcare for Older People, Royal Devon University Healthcare NHS Foundation Trust, Barrack Road, Exeter, UK
- 5UConn Center on Aging, University of Connecticut, Farmington, CT, USA
- 6Connecticut Convergence Institute for Translation in Regenerative Engineering, University of Connecticut, CT, USA
- ↵*Corresponding Author
Professor David Melzer, College House (1.07), University of Exeter St. Luke’s Campus, Magdalen Road, Exeter, EX1 2LU, D.Melzer{at}exeter.ac.uk
Posted February 14, 2023.
Combining pharmacogenetics and patient characteristic polygenic scores to improve outcome prediction for Calcium Channel Blocker treatment
